Clinical trial
Sexual Functioning Study With Antidepressants
NCT00316160 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00316160 |
|---|---|
| Title | Sexual Functioning Study With Antidepressants |
| Official title | A Twelve-week, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group, Active Controlled, Escalating Dose Study to Compare the Effects on Sexual Functioning of Bupropion Hydrochloride Extended-release (WELLBUTRIN XL, 150-450 mg/Day) and Extended-release Venlafaxine (EFFEXOR XR, 75-225… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major, Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | Bupropion Hydrochloride Extended-release, Extended-release Venlafaxine |
| Enrollment | 347 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Apr 20, 2006 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: